Understanding where and how chemicals are used throughout their life cycle is becoming increasingly important. In 2003, within the context of REACH and GPSD legislation, the European Commission started developing a European and global infrastructure of exposure methods and tools. The infrastructure aims (1) to link modeling tools and exposure-related data and scenarios in a single framework so that harmonized exposure assessment procedures can be developed for consumer products in the EU and (2) to make this framework flexible enough to allow global application. A number of issues are raised by a global infrastructure of consumer exposure modeling that answers to multi-legislative mandates. These include transparency, consistency, usability, and defensibility of the models, including the relevant degree of complexity for priority setting versus assessment. As part of the initiative to set up a harmonized global infrastructure on consumer exposure assessment, these issues were presented, discussed, and further developed in a series of European Commission-sponsored workshops organized in October 2004 and June 2005 as part of the ''Harmonization of Consumer Exposure Models on a Global Scale'' project. The project focused on development, harmonization, and validation of consumer exposure modeling approaches. The workshops included experts from the EU, USA, Japan, and Canada. The conclusions and recommendations made on the basis of this work are described. To help achieve harmonization of approaches, the European Commission's Joint Research Centre is proposing a framework (1) to compare information on elements of chemical risk assessment to understand exposure regulations in different countries, (2) to save time and expense by sharing information and models, and (3) to promote credible science through better communication among organizations and by peer review of assessments and assessment procedures.
Introduction
Understanding where and how chemicals are used throughout their life cycle is becoming increasingly important owing to legal obligations under the General Product Safety Directive (GPSD, 2001 /95/EC) and the EU regulatory framework for the Registration, Evaluation and Authorization of Chemicals (REACH regulation, (EC) No. 1907 . A significant number of chemicals are used in numerous formats (mixtures, matrices, etc.) to produce consumer products, such as detergent products, personal care products, consumer electronics, clothing, furniture, and toys. To facilitate a better understanding of chemical usage in consumer products and to assess the potential exposure involved with various consumer uses of these products, (i.e., normal use/foreseeable use, accidental use, or misuse), new mechanisms of communication will be required. Along with this requirement, in 2003, the European Commission started developing a European and global infrastructure of exposure methods and tools with the following aim:
to link modeling tools and exposure-related data and scenarios in a single framework so that harmonized exposure assessment procedures can be developed for consumer products in the EU and to create enough flexibility within this framework to allow global application.
With a few exceptions (such as food contaminated by residential pesticide application or packaging material), this EC initiative does not cover food, beverages, or medicines as exposure pathways. The development of consumer exposure modeling approaches within one global infrastructure that answers to multi-legislative mandates requires systematic consideration of all chemicals, and raises a number of issues. These include transparency, consistency, usability, and defensibility of the models, including the relevant degree of complexity for priority setting versus assessment. Experiences arising from GPSD and REACH implementation in the European Union emphasize the need to address these issues within a worldwide perspective. In particular, REACH refers to the use of appropriate models to estimate exposure levels for relevant human populations, including consumers. For certain exposures, it is appropriate to specify vulnerable subpopulations, such as children or pregnant women. In these particular cases, it is extremely important to determine correct exposure factors, such as exposure route or frequency of exposure, which will be used as input parameters during the modeling exercise(s). In addition, the uncertainty arising from the variability in the experimental data and from intraand inter-(sub) population variation and sensitivity needs to be taken into account ( To achieve harmonization of approaches, a framework is being proposed by the European Commission's Joint Research Centre (EC JRC). This framework can be used for the following purposes:
to compare information on various elements of risk assessment, including exposure modeling; to understand exposure standards for specific chemicals in different countries; to save time and expense by sharing information and models; and to promote credible science through better communication among organizations and by peer review of assessment procedures.
In the context of exposure modeling, the goal is that reliable exposure and risk assessments lead to effective and targeted risk management decisions, thus promoting protection of human health and the environment within the framework of sustainable development. The principles of exposure model harmonization are intimately tied to basic concepts and determinants of human exposure, and how this information is linked with data on exposure conditions and human behavior.
As part of the initiative to set up a harmonized global infrastructure on consumer exposure assessment, these issues were presented, discussed, and further developed in a series of workshops organized in October 2004 (WHO IPCS, 2005) . The formulation of WHO IPCS's 10 principles took into account the experience gained in the EC JRC's Exposure Modeling Task Force exercise. These 10 principles and related specific questions cover the following:
(a) General model description ((1) description of the model purpose and its components, (2) individual or population level analysis (level of aggregation), (3) modeled time resolution, and (4) applicability to diverse exposure scenarios); (b) Model inputs ((5) description of data inputs); (c) Model processes ((6) modeling tool methodology, (7) model code and platform, and (8) model performance and evaluation summaries); (d) Model outputs ((9) description of model outputs and (10) model sensitivity and uncertainty).
In the Global CEM Net Workshop ''Consumer Exposure Models Inter-comparison (Phase I) F The State of the Science and Research Needs'' held in Ispra, Italy, on 26-27 October 2004, the characteristics of the models mentioned above were discussed. Some of the models were compared across four scenarios ((1) consumer spill; (2) treated-wood used indoors; (3) VOC from painted wallboard indoors; and (4) exposure to the pesticide ''Woebegone'' applied to control crawling insects). It should be noted that these scenarios were provided for model analyses purposes only. Subsequent analyses of the results, along with discussion of past experiences in EU and USA, led to the emergence of two primary issues: (1) framework of modeling and (2) scientific research needs.
Specifically, issues included harmonization, complexity versus accuracy, tiered approach to exposure/risk assessment, vulnerable subgroups versus general population, uncertainty (variation versus ignorance), exposure scenarios, and data availability. These issues must be clearly differentiated as science-related or policy-related. Some were recognized to be ''in-between'' and connected to both.
During the 
Consumer Exposure Modeling Framework
In Workshop 1, ''Dermal transfer and penetration algorithms'', the discussions focused on the utility of current penetration algorithms; processes evaluating the dermal risks accurately; the need to better understand the relationship between dermal exposure and absorption (especially the effect of vehicles, matrices, and reservoirs); and the need to generate more information on data outside the applicability domain ('happy domain') of the quantitative structure-activity relationships (QSARs; Netzeva et al., 2005) corresponding to the Potts and Guy equation (Potts and Guy, 1992) . The outcome of Workshop 1 on ''Dermal transfer and penetration algorithms'' is thoroughly discussed in van de Sandt et al. (2007) .
The human health risk assessment process can be represented as a continuum from source through exposure and dose to health effects (US EPA, 2003) . Knowing the sources of exposure is, therefore, essential for development and implementation of any mitigation policy. Therefore, Workshop 2, ''Source characterization, transport, and fate'', built up a framework on source characterization and taxonomy, as well as a similar framework for transport and fate models. In Workshop 3, ''Exposure modeling framework issues'', a generic exposure modeling toolbox was visualized as a Issues in consumer exposure modeling Kephalopoulos et al.
concentric shell structure. The core defines its fundamental logical structure F the conceptual model. The inner shell contains the model algorithms (e.g., deterministic or empirical with varying degrees of detail and complexity). The core and inner shell form the model.
The user of a computerized model, however, rarely sees the model. He or she is interacting with the outer shell, which is not a part of the model, but of the modeling toolbox. It contains the default values and databases that are used by the model as input data (e.g., time-activity, exposure scenarios, chemicals and their characteristics, etc.). The outmost layer is the user interface.
The development of a harmonized consumer exposure modeling framework first relied on the identification of commonalities and differences in the structure and data requirements of the consumer exposure models included in the Global CEM Net database. An attempt was made to achieve this by comparing and classifying some of these models (Notitia/CARES, Lifeline, ConsExpo, BEAT) according to the aforementioned concentric shell structure. In Workshops 4 and 5, ''Exposure-related data'' and ''Exposure scenarios'', respectively, first attempts were made to identify exposure scenarios required for different purposes, both in Europe (for different frameworks such as REACH) and outside of Europe (e.g., USA and Canada); make an inventory of reference exposure scenarios; prioritize the scenarios mostly needed in consumer exposure modeling; identify the drivers of exposure in the different scenarios to which assessors should pay attention when collecting data; review the level of detail (and tiering) needed for a given assessment; and assess the extent to which we can model all necessary scenarios and where the gaps are.
A list of focal issues concerning the development of exposure scenarios was elaborated.
Subsequently, the requirements for consumer exposure models set by different regulatory applications as well as the requirements of the models themselves were taken into consideration. Finally, the harmonization potential and challenges of the existing consumer exposure models were evaluated, and actions for the development of a harmonized consumer exposure modeling framework on a global scale were suggested. All discussions are summarized in the next chapter.
Discussion and Results
Results of the IPCS Harmonization Project were adopted as a starting point. The IPCS project did not imply global standardization. Instead, harmonization was thought of as an effort to strive for consistency among approaches and to enhance understanding of the various approaches to chemical risk worldwide (WHO IPCS, 2004 . Thus, harmonization was defined, in a stepwise fashion, as an understanding of the methods or models and practices used by various countries and organizations so as to develop confidence in, and acceptance of, assessments that use different approaches. It further involved a willingness to work towards convergence of these approaches or models as a long-term goal.
Development of a Harmonized Consumer Exposure Modeling Framework
In the Global CEM Net Workshop 3 ''Exposure modeling framework issues'', it was agreed that the harmonized consumer exposure modeling framework should identify the model information needs and the supporting structures necessary to deliver and manage these.
Idealized visions foresaw an open modeling universe capable of describing person and/or event-oriented exposures through life with Bayesian integration of multiple scenarios.
The extent to which models rely on differing quantities and dimensions of data (their ''data intensity'') and their relationship to data sources (databases) was identified as an area requiring more attention (e.g., an evaluation of the adequacy of existing databases for key determinants such as consumer product contact rates, use frequency, etc.).
Requirements for the Models
The users of the model, scientists and other stakeholders, must be able to trust that the applied model is founded on a relevant, transparent exposure scenario with a known, acceptable uncertainty range. Alternatively, users must trust that comparison of alternative exposure scenarios sets scenarios in correct relative/rank order, that is, that the model is valid for that particular application.
Confidence in model use and estimates is increased when (a) the exposure determinants (''drivers of exposure''), such as exposure routes, exposure media, and relevant consumer behavioral factors, like consumer product use, consumption, and time-activity are correctly identified; (b) the computer code is verified against the theoretical conceptual model, and the model is validated against measured exposure data to ensure that the conceptual model captures the essential factors; (c) sensitivity analyses help policy makers and risk assessors to identify the most influential input variables; and (d) model transparency and documentation is provided to both the regulatory authorities and scientific communities.
The model's validation conditions and outcomes, input data, and conditions/limitations/uncertainties need to be transparent, although not necessarily easily comprehensible to all stakeholders. Model transparency requires that the model is fully documented, with documentation available according to the 10 requirements of WHO (WHO IPCS, 2005).
Model management includes comprehensive documentation with historic record of model versions (including the changes made and the reasons for them), documentation of the model validation exercises (scenarios, input data, and independent validation data), and, ideally, compilation of the model application references and experiences.
Requirements of the Models
Modeling human exposure to a chemical requires the integration of information about source emissions and multimedia environmental concentrations of the chemical with pathway-specific exposure factor information (location, duration, frequency, intensity, and human activity).
The following four key ingredients of consumer exposure models were identified:
1. consumer products usage information, such as product brand name, application rates, frequency, and location of use; 2. scientific theories, mathematical formulations, computational algorithms, and computer codes used to describe the emission, transport, and fate of product chemicals in the microenvironment associated with product use; 3. information or algorithms that estimate personal exposure from microenvironmental chemical concentrations, human time location activity patterns associated with product use; and 4. compiled, computed, and measured values and distributions for chemical source release, microenvironmental chemical concentrations, exposure factor estimates (e.g., inhalation rates, product use, time-microenvironmentactivity data), or metabolic parameters (e.g., uptake, absorption, elimination, pharmacokinetic parameters) of product chemicals.
Consumer exposure models need input data for substances, contact media, concentrations, and contact rates. Databases of chemicals are available in published reports and on the internet (e.g., http://ecb.jrc.it/existing-chemicals/, http:// www.inchem.org/, and http://chemfinder.cambridgesoft. com/). Such data are also available in handbooks on chemical properties.
Media concentration data range from easily available to complex and difficult to find. Data on contact rates are often still more difficult to obtain. These include product use or contact frequencies, intensities (e.g., the skin contact area of a particular textile), and durations (e.g., the time spent in a freshly painted room). Several consumer product information databases exist in the United States, such as the National Library of Medicine's Household Product Database (http:// householdproducts.nlm.nih.gov/index.htm) and the Tox Town Database (http://toxtown.nlm.nih.gov/city/main.html). However, these consumer products databases do not contain information about product usage in terms of directions for use, application rates, or frequency of use. Such information may be classified research results of commercial interests or simply nonexistent.
Because contact rates depend on socioeconomics, demographics, and behavior, complex background data are often required for population-level contact rate assessment for most consumer products. Existing human exposure databases, such as the US Human Exposure Database System (HEDS) or Consolidated Human Activities Database (CHAD), or exposure factor databases, such as the European ExpoFacts database (http://www.ktl.fi/expofacts, Vuori et al., 2006) or the US EPA Exposure Factors Handbook (http://cfpub.epa.gov/ncea/), are particularly weak on contact rates of consumer products. Although little or no product usage or brand information is available, however, these databases do maintain raw records and file structures to support data storage, retrieval, and analysis of consumer product exposure data.
The US consumer exposure models include E-FAST, SCIES and DERMAL, and MCCEPA. Generally, these models are used to screen chemical exposures for (a) indoor air pollutants, (b) dietary contaminants, including those in drinking water, and (c) consumer product exposure from high production volume chemicals (HPVCs) used for products like general purpose cleaners, laundry detergents, interior paints, bath soaps, motor oil, and residential pesticides. More comprehensive and sophisticated models are under development, such as the Stochastic Human Exposure and Dose Simulation (SHEDS) modeling system, for multimedia and multipathway exposures of the general population and vulnerable subgroups. The success of SHEDS and other models like Lifeline, however, is contingent on the availability of consumer product use information and time-microenvironment-activity data.
Classification of Consumer Exposure Models
Consumer exposure models can be classified along many dimensions: (a) simplicity-complexity; (b) science-policy; (c) descriptive-predictive; (d) scenarios, event-reasonable worst case-target population (group); (e) single source-multiple sources; (f) exposure media, exposure pathway, and route of entry.
Simplicity-complexity Simple tier 1 models are made for quick screening and first-order compliance testing using deterministic algorithms, few inputs, and reasonable worstcase exposure scenarios. They provide daily or annual average exposure estimates.
Tier 2 models incorporate more details concerning concentration and time-activity profiles of study populations.
Complex tier 3 models have been developed to assess realistic population exposure distributions. Distributions include algorithms for agent dispersion and transformation in different environmental settings and media. They also incorporate probabilistic data sampling from representative input databases, including exposure scenarios (e.g., daily itineraries), and apply Monte Carlo simulation, etc. Tier 3 models are typically used in regulatory analysis.
Science-policy Scientific model development aims at producing the most realistic and comprehensive conceptual exposure models, exposure algorithms, and databases of exposure factors and exposure scenarios. These models should be validated with real-life data, and they should meet both precision and accuracy requirements.
The models for policy support fall into two categories: (1) tier 1 conservative first-order screening models as described above, and (2) tier 2 and 3 models aimed at producing output, which directly serve the regulatory requirements, and are maximally comparable for different products, exposure scenarios, and policy alternatives. More important than accuracy is correct rank ordering in comparing alternative scenarios.
Many regulatory decisions are, by necessity, based on screening models. For new chemicals, we sometimes have only expert judgement and common sense to make critical assumptions.
Descriptive-predictive Descriptive models are usually empirical and data-driven. They are not founded on the known or selected physical/chemical causalities from sources via release/dispersion to targets, but instead on statistical relationships between the input and output variables. Because of their empirical nature, they incorporate the impacts of all affecting parameters, known and unknown; however, they should, in principle, be only quite cautiously applied outside of the original (or similar) exposure setting.
Predictive models are driven by scientific causality, based on numerical constructs, which mimic physical reality, to a varying degree of detail. Therefore, predictive models can be theoretically applied anywhere the data allows but their capabilities are limited by the built-in physical/chemical knowledge. Even simple predictive models may describe reality with sufficient accuracy for risk assessment. However, for risk management application, such as policy options evaluation or implementation follow-up, the model must realistically incorporate the impacts of all those key input variables, which significantly influence the resulting exposure level, and for which the evaluated options (products, scenarios, etc.) differ from each other.
Scenarios event-reasonable worst case-target population (group) Population exposure is commonly assessed via the use of exposure scenarios. For event and reasonable worstcase assessments, the scenarios are usually artificial, agreed upon between the stakeholders. The key quality requirements for using these approaches are the comparability and ranking of the exposure situations. Mostly, however, they do not result in realistic exposure predictions. For target populations (such as children, pregnant women, etc.), the scenarios should be reality-based and should reflect the true range of real-life exposure variation within the target group. Often, the emphasis is on realistic modeling of the high end (e.g., 95th percentile) of the population exposure distribution.
Single source-multiple sources Consumer exposure models typically focus on modeling the exposure from a single source (i.e., the consumer product of interest). These models are referred to as single-source models. In contrast, there are multisource empirical (statistical/descriptive) exposure models incorporating all sources of interest.
Although exposure to a given agent resulting from the use of a consumer product is often assessed independently of the exposure to the same agent from other sources, it is recommended to assess consumer exposure in relation to the total exposure. The same consumer exposure may warrant different action if it is 90% versus 10% of the total exposure to the agent of concern.
Source apportionment models should be mentioned in this context. Instead of modeling exposures from source data, they are used to assess the existence and contributions of different sources to measured exposures (source apportionment models are summarized in Bruinen de Bruin et al., 2006) .
In Workshop 2, ''Source characterization, transport, and fate'', modeling of source terms and fate and transport processes used in consumer exposure assessments has greatly evolved. The workshop developed a taxonomy of these generic source models from the ground up in a tiered approach to facilitate the development of new models and improvement of the existing ones. This taxonomy establishes a family of models varying in complexity from those appropriate for simple screening (conservative models that require minimal data) to complex models that accurately describe releases, but require extensive programming, computer resources, and considerable compound-and product-specific data.
The workshop suggested a number of work products including a report on existing source models, the taxonomy of source models, and the attributes and characteristics of source and transport/fate models organized in a tiered approach for use in various levels of exposure assessment. To the extent that this will result in tools that facilitate realistic exposure estimates for a broad base of scenarios and substances, the research and development efforts would be cost-effective.
The specific selection of which area(s) to focus on should initially be guided by the stakeholders and the regulatory mandate(s) under consideration. For example, take the case of an initial implementation of the REACH program that is limited to priority assessment of chemical substances designed for release into the environment. If such is the case, then the initial research and development should focus on emissions from wet sources or on particulate matter sources in scenarios where release is intended as part of the material's use.
Decision-Making, Model Use, and Requirements
Policy makers, risk assessors, and exposure modelers all have their own requirements for the models.
To support decision-making, policy makers need reliable information on potential risks, their magnitudes, and comparisons of the risks of alternative scenarios. After defining the scenarios to be modeled, risk assessors provide this information to exposure modelers. Risk assessors should provide information including the selection of chemicals, exposure routes, and modeling approaches, and, in return, require exposure estimates from the modelers. Subsequently, risk assessors must evaluate the reliability of exposure estimates. Therefore, there is the need to understand the properties of the exposure model. This requires that model performance tests be available and clearly documented. Exposure modelers are responsible for model definition, model input data collection, model evaluation and running, and documentation and reporting of the results.
The regulatory process is a political one that requires modeling to correctly compare the alternatives. Hence, transparency of the modeling process is essential. It is also important for stakeholders with very different interests to participate in the risk assessment process. Complexity limits transparency and restricts comprehension by the nonexperts. Documentation of the concepts, technical details, and uncertainties of the models is a key element for transparency.
Overall, requirements set for consumer exposure modeling as part of the risk assessment process include reliability, transparency, comparability, clarity, and description of variability.
Consumer Exposure Scenarios, Models, and Assessments The goal of the consumer exposure assessor is to estimate the magnitude of exposure to a substance that consumers may experience as a consequence of its presence in, and use of, one or more consumer products. Description of the appropriate consumer exposure scenarios is, therefore, one of the basic elements in the process to estimate consumer exposure. Other important elements include the development of mathematical models that reflect the scenarios, assignment of values to the models' parameters, and an understanding of the physico-chemical properties of the substance and the products in question, etc.
In this context, exposure scenarios can be understood as descriptions of the circumstances and conditions that lead to consumer exposure to a substance or substances. Exposure scenarios should take into account the types of products in which the substance is present, the usage characteristics of the products, and, based on these, the likely relevant exposure routes.
Consumer exposure to substances may occur (a) as a consequence of direct usage of the product and (b) indirectly from any remaining presence of the substance in the consumer's immediate environment after product usage has ended. Separate scenarios are usually needed to address these two types of product use-related exposures. It is reasonable to assume that exposure derived from direct product usage will likely be the main source of consumer exposure to a chemical present in that product.
The nature of an exposure scenario should be consistent with the purpose of the exposure assessment and the overall risk assessment being considered. On the one hand, very generic scenarios can be developed that cover broad product categories. Such scenarios, however, may lack a detailed description on the use-and exposure-related information. On the other hand, very specific scenarios can be made that are extremely detailed for one type of usage of one type of product. Tiered approaches can be developed, where a progression from generic scenarios to more specific ones is part of the exposure and risk assessment process. The type of mathematical model that is assigned to an exposure scenario should also be consistent with the scenario's level of detail. For all chemicals used or released, looking to new and existing products is recommended. Since there is no alternative to the tiered approach, available data should be used initially. If necessary, more detailed models can be used and, in the extreme case population-based field studies.
The above basic and obvious considerations about consumer exposure may be useful to clarify that the term ''exposure scenario'' can be used differently by different people. This is especially the case, in the context of REACH, where exposure scenarios are defined differently.
In REACH, Annex I, ''an exposure scenario is the set of conditions that describe how the substance is manufactured or used during its life-cycle and how the manufacturer or importer controls, or recommends downstream users to control, exposures of humans and the environment.'' So an exposure scenario provides a set of conditions for human health and the environment. The key point with regard to consumer products is how to adequately control the consumer exposure. The REACH definition should therefore only be discussed with regard to its content, not the term itself. An exposure scenario in REACH outlines the operational conditions and risk management measures needed to adequately control the risks from a given use of a substance (many of which are used to manufacture consumer products). How narrow or broad should the scenarios be? It is clear that they should cover many kinds of uses, products, and processes. Also obvious is that, the more hazardous the substance is, the more detailed the REACH assessments need to be. There has been a lot of discussion on the REACH definition of exposure scenario, including whether it is appropriate to include risk management measures in the exposure scenario, as well as the challenge Issues in consumer exposure modelingof arriving at one exposure scenario that covers environmental, occupational, and consumer exposure.
After a scenario is developed and the relevant exposure routes are identified, algorithms need to be established to calculate intermediate variables and exposure estimates. Source models will output chemical release rates in the use environment. The nature of the product will impact on whether the chemical of concern is in the gaseous (air) or particulate (dust, droplets, etc.) medium. Accordingly, a relevant transport model will be used to determine chemical levels in the use environment. Chemical levels can be determined in the breathing zone as volume concentrations and in contactable surfaces as area concentrations. Breathing zone levels will result in inhalation exposures, whereas contactable surface levels will result in dermal exposures and, for infants and toddlers, incidental ingestion exposures owing to hand-to-mouth behavior.
In summary, a scenario will be established by a subpopulation of interest using a consumer product that contains the chemical of concern. The scenario will decide the relevant exposure estimation algorithms. Availability of data and the sophistication level of the assessment (deterministic versus probabilistic) will dictate the use of an appropriate model.
There are thousands of exposure scenarios, assessed only by a few assessment methods. When constructing a scenario, the following questions must be asked:
Should the assessment be population-or individual-based? What time frame we are interested in? Should multiple products be addressed?
Concerning the models, the same algorithms can be used for different scenarios. Algorithms can help to build the scenarios; however, to run a model, parameters are needed. It is therefore important to start with the appropriate question, which determines the final definition of the scenario.
There are different levels in the exposure assessment referring to different purposes, using different models. The utility of those models must be constrained by the limits of those levels. Determinants of the level of detail in consumer exposure assessment include for whom and for what purpose are the assessments made, and the time and resource constraints.
The exposure scenarios and data may contain meaningless details and levels of precision. The level of detail is in no way correlated to the uncertainty of the assessment. Increasing levels of detail may, in fact, lower the user confidence because the model may become incomprehensible. The scenario plus the details determine the selection of the model. Academics and consultants tend to complicate, whereas regulators and industry tend to simplify. If validation is possible, then it is also possible to find the simplest model/scenario that meets the accuracy requirements.
The same scenario with different data details may correspond to different tiers. A focus only on data-rich substances will never uncover most of the chemicals that cause problems.
An essential part of an exposure and risk assessment process is the qualitative and quantitative characterization of scenario, model, and parameter uncertainties based on a tiered approach. If uncertainty is not considered, it is difficult to assess whether two probabilistic exposure assessments are consistent. The assessor must have the opportunity to reevaluate the aims, scenario, model approaches, and inputs of the analysis, and to consider the key factors influencing exposures and risks during the decision-making process (WHO IPCS, 2006) .
A huge number of substances need to be taken into consideration for consumer products, and thus a tiered system is needed to find out where to dedicate resources. Tiers address the high throughput, not the definition of scenario.
In REACH, a generic modeling tool is needed that is based on, for example, physical chemical properties and can estimate releases from articles or from different matrices or types of articles. The question has been whether, based on the information available today, a quick tool can be developed to produce first estimates of potential releases. This demand stems from the fact that REACH will be a high-throughput system, so many substances will be registered. Therefore, a tool that can evaluate whether a problem exists is of utmost importance.
The US experiences arising from the development of approaches to aggregate and cumulative exposure were reviewed and summarized as being ''data rich, model poor''. It was suggested that the availability of data can determine the design of a model as much as the purpose of the model. Specifically, the models require design choices concerning the use of the major surveys of activity patterns, dietary surveys, and demographic information. Different choices on how to use the data result in different modeling designs. The implications of this are, however, that many versions of a model may be required.
Furthermore, model comparisons across the different models have not been easy and have required considerable resources. In the future model, comparisons may become even more challenging. Often, the modeler's expectations for perfection can exceed reality. It was therefore suggested that model validation and inter-comparison should be made at early stages of model development. The discussion can then be substantive but not so far-reaching that there is little likelihood of future change. Potential solutions to some of the preceding issues may lie in better definitions of applicability domains. There are needs to (a) define the scenarios where the models are useful and (b) identify the models that may be useful for a particular scenario. The JRC/IHCP/PCE Unit is preparing a proposal that enables consumer model inter-comparisons to be made taking into account key scenarios and available models and data. Such a comparison must consider the accuracy of the models themselves and whether the model's predictions are sufficiently similar to allow comparison. The idea is to develop a generic framework by which models/approaches can be inserted, so the end user will be guided on what to use, when, and how (i.e., to include screening levels as well as more refined evaluations).
Benefits of Consumer Exposure Model Harmonization
The benefits of exposure model harmonization include the facilitation and promotion of model quality assurance (QA), clear and transparent description of the purpose, structure, and recommended application of the model, consistency in documentation and presentation of model inputs, assumptions, and outputs, guidance on proper selection and application of models, description of variability and uncertainty in model results, capability to compare and contrast results from different models, evaluation of model performance, peer-review to build confidence in model results, and better informing of risk assessors and managers about the best use of models in both research and regulatory evaluations.
Model Harmonization Opportunities and Potential
Consumer exposure modeling tools vary greatly because of different fundamental approaches, application purposes, exposure pathways and routes of entry, and the different regulatory approaches and data availabilities in the different countries. These complexities and differences obviously limit the opportunities for model harmonization. The objective for European and global consumer exposure model harmonization should be to identify and reduce those current differences, which are set by available data, and to critically review those that are due to different modeling approaches. Globalization of consumer product manufacturing, markets, and risk assessment would benefit from, and act as driving forces for, harmonized exposure modeling approaches, as well as consumer product information, exposure factor data generation, and availability. On the other hand, model harmonization should not be allowed to restrict the advancement of science or the development of new modeling approaches and tools.
Model harmonization is not practical across all model applications. It is more fruitful to aim at identifying the model components for which harmonization would bring benefits than to try to harmonize the functioning and performance of entire modeling tool packages.
Harmonizing the conceptual models would ensure similar constructs and objectives when modeling similar exposures. Harmonizing the equations/algorithms would ensure that the same logic, physical, and chemical phenomena are modeled, which are the first requirements for result comparability.
Harmonizing model algorithms (model modules) will, in principle, ensure that for the same data input similar results would be obtained by different models. Both of these harmonization benefits are universal, independent of model application region or purpose.
Harmonizing the outer shell is essential within a region or application, where result comparability is essential (more so than accuracy) for administrative purposes. When the model application objective is realistic exposure assessment for risk comparison in a specific case, harmonization of the formats and quality requirements of the outer shell databases and scenarios would still be beneficial for comparability and model use convenience, but harmonization of the contents of these databases would be detrimental for the assessment. For the latter type of analyses, the databases should, obviously, maximally reflect the realities of each exposure setting.
The current framework focuses on harmonization of consumer exposure assessment modeling methodologies. In principle, many of the core issues identified here also apply to environmental and occupational exposure assessment practices. Issues such as model requirements, classification, performance and user confidence, use, uncertainty and variability, exposure scenarios, data selection, and the benefits and challenges from harmonization can also provide some initial guidance for harmonization practices of environmental and occupational exposure assessment.
Model Harmonization Challenges
Within the consumer exposure model harmonization framework the following challenges exist: creation of a general understanding on the existence and details about models; difficulties in accessing and performing comparative model evaluations and ground-truthing complex models; the unfinished status of many models; different modeling interests of decision makers (regulatory) and scientists (research); the limited availability of information on applicability of models for addressing different scenarios and problems; tiered classification of models possibly dependent on the specific problem or application; models that may not be generalized to a broad set of scenarios/situations (e.g., empirical models); original model developers and users needing to document/ publish model characteristics relevant to the harmonization principles; broader harmonization of models that will be time-and resource-intensive; harmonization requirements that may slow down model development; and Detailed planning of who should and how one should organize/conduct model harmonization; this role was suggested to be undertaken by the Global CEM Net coordinated by the JRC/IHCP/PCE.
Conclusions and Recommendations
Within the framework of consumer exposure modeling harmonization, two events were organized by the Global CEM Net coordinated by the JRC/IHCP/PCE. The first event was a workshop organized in 2004 with the aim to identify the needs for model harmonization, validation, and guidance development on a global scale on the basis of common procedures and protocols. As a follow-up, the Global CEM Net organized in 2005 a series of five specialized workshops during which these needs were further elaborated and, when possible, translated into requirements for the harmonization and validation of the consumer exposure models. (Global CEM Net, 2006a-e) The conclusions drawn and recommendations made on the basis of this work are as follows:
1. A harmonized consumer exposure modeling framework should be linked to a standardized and documented regulatory procedure, which is a combination of experience, related data, transparent validated models, and common sense to make critical assumptions. To create such a harmonized framework, communication between regulatory authorities and scientific community should be reinforced. Emphasis should be put on harmonizing model terminology in addition to the already created exposure-related terminology by WHO IPCS. 2. A framework should be developed that sets out the different forms (tiers) of assessment that are routinely applied in the evaluation of consumer exposures/risks. This framework should also identify what data expectations are associated with each tier and the models that are available to support them. The framework should account for the activities across global regulatory arenas and should be used to better coordinate these activities. 3. With respect to the models themselves, there is a need to define their applicability domains more clearly. These should include the scenarios where the models are useful. There is also a need to identify the models that may be useful for a particular scenario. 4. A library of consumer exposure scenarios should be compiled, together with supporting frame formulations for the typical consumer products and/or articles encountered in each scenario. 5. It was considered that more attention should be paid to (globally) sharing available data. A constraint to this is the availability of suitable data exchange formats, for example, the IUCLID activity in support of effects data. In terms of database structures, the adequacy of the utility of existing databases should first be evaluated, particularly for determinants considered especially critical in consumer exposure assessments (e.g., consumer product contact rates, product percentages, use frequency, etc.). Much data are available, but are not either effectively shared or made available. Moreover, some data are demanded by models but which may not be prime in reality or even illusory (required by models but difficult to ascribe in practice). Health Canada recounted the strategy they have developed for profiling chemical exposures via the use of publicly available information. 6. Data that describe the effects of inter-and intra-subject variability over time are sparse. There is a need to consider how to assemble and summarize relevant data sources in a manner that would enable them to be better characterized and accounted for. It is an important challenge as the expectations for the scope and detail of the exposure assessments continue to develop (e.g., aggregate, age profile, etc.). 7. The process for model evaluation and verification needs to be given more prominence in the overall framework for consumer exposure (and risk) assessment. A key questions is ''do the models realistically reflect real life exposures?'' The data needed to verify the models should be more clearly stated. In this respect, it matters less whether the data originate from models or reality, but more whether the level of certainty associated with the data is appropriate. 8. Exposure assessments vary with the role they play in decision-making process. An exposure scenario has to be defined depending on the level and aim of the assessment.
The choice of any model, whether simple algorithm or complex software, is influenced by the exposure assessment scenario under investigation. But the model choice is also determined by the purpose of the exposure assessment (e.g., population versus individual; typical versus reasonably worst case; single event versus repeated; and so on). The model then affects the scope and quality of the data (information) needs. 9. Available models (see 2) should undergo comparisons for the tiers/scenarios they are intended to address. It is recognized that such exercises are difficult and not cheap. However, costs can be reduced by undertaking model validation and comparison at an early enough stage of development so that the discussion can be substantive but not so far that there is little likelihood of future change. A first step could be the comparison of available consumer models for key scenarios identified. Test cases should be chosen to reflect exposure by different routes. 10. Existing first principle mechanistic source and transport/ fate models should be identified and evaluated in a tiered approach. A taxonomy of sources for consistent data sharing should also be developed. 11. There is a mix of models, databases, and interaction among them. One way to effectively handling this interdependency is to create a database-driven modeling system under a generic modeling environment designed in a modular fashion that allows selecting different algorithms and associated data inputs. The setup of such a generic consumer exposure modeling framework platform was undertaken by the EC JRC/IHCP/PCE. Besides this, the EC JRC follow-up actions include the development of a protocol for consumer exposure model inter-comparison and validation exercise, the building of a taxonomy and validation of source models, fate and transport models, and the preparation of a guidance document on model selection for different regulatory applications.
